ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing April 9, 2020, 4:00 pm ET: 

Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer (Original Report)
Matthew Galsky, et al.
Request this article

Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx (Original Report)
Lynne Wagner, et al.
Request this article

Publishing April 8, 2020, 4:00 pm ET: 

Challenges Faced by Medical Journals During the COVID-19 Pandemic (Special Article)
Stephen Cannistra, et al.
Request this article

Survivorship Care Plans and the Commission on Cancer Standards: The Increasing Need for Better Strategies to Improve the Outcome for Survivors of Cancer (Editorial)
Anne Blaes, et al.
Request this article

Successful Model for Guideline Implementation to Prevent Cancer-Associated Thrombosis: Venous Thromboembolism Prevention in the Ambulatory Cancer Clinic (Original Contribution) 
Chris Holmes, et al.
Request this article

Variations in Retroperitoneal Soft Tissue Sarcoma Outcomes by Hospital Type: A National Cancer Database Analysis (Original Contribution)
Anthony Villano, et al.
Request this article

Publishing April 7, 2020, 4:00 pm ET: 

Breast Cancer: 45 Years of Research and Progress (Special Article)
Gabriel Hortobagyi, et al.
Request this article

Bridging the Gap Among Clinical Practice Guidelines for Pain Management in Cancer and Sickle Cell Disease (Original Report)
Jamie Aughenbaugh, et al.
Request this article

Formal Assessment of Teamwork Among Cancer Health Care Professionals in Three Large Tertiary Centers in Nigeria (Original Report)
Blase Polite, et al.
Request this article

Publishing April 6, 2020, 4:00 pm ET: 

Postdiagnosis Body Mass Index, Weight Change, and Mortality From Prostate Cancer, Cardiovascular Disease, and All Causes Among Survivors of Nonmetastatic Prostate Cancer (Original Report)
Ying Wang, et al.
Request this article

Publishing April 3, 2020, 4:00 pm ET: 

Clinical Characteristics and Outcomes of Caribbean Patients With Adult T-Cell Lymphoma/Leukemia at Two Affiliated New York City Hospitals (Original Report)
Edwin Chiu, et al.
Request this article

Publishing April 2, 2020, 4:00 pm ET: 

Barriers to Participation in Therapeutic Clinical Trials as Perceived by Community Oncologists (Original Contribution)
Mina Sedrak, et al.
Request this article

Gamma Gap: A Point-of-Care Test That Correlates With Disease Burden and Treatment Response in Multiple Myeloma (Original Contribution)
Yubin Kang, et al.
Request this article

Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting ALK and ROS1 Fusion and Resistance Mutations in Patients With Non―Small-Cell Lung Cancer (Original Report)
Pierre Saintigny, et al.
Request this article

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.